Ignite Creation Date:
2025-12-24 @ 3:04 PM
Ignite Modification Date:
2025-12-29 @ 9:47 AM
Study NCT ID:
NCT04908059
Status:
UNKNOWN
Last Update Posted:
2021-07-08
First Post:
2021-05-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Leukemic Phase of ALCL
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'OTHER', 'observationalModel': 'CASE_ONLY'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 2}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'RECRUITING', 'startDateStruct': {'date': '2021-01-27', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2021-05', 'completionDateStruct': {'date': '2021-07-13', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2021-07-07', 'studyFirstSubmitDate': '2021-05-26', 'studyFirstSubmitQcDate': '2021-05-26', 'lastUpdatePostDateStruct': {'date': '2021-07-08', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2021-06-01', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2021-07-13', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'A retrospective study of the diagnostic description of the leukemic phases of anaplastic lymphoma in real life', 'timeFrame': 'Files analysed retrospectively from January 01, 2020 to December 31, 2020 will be examined]'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['Anaplastic lymphoma', 'Leukemic phase'], 'conditions': ['Anaplastic Lymphoma']}, 'descriptionModule': {'briefSummary': 'Collecting data about the rare leukemic presentation of anaplastic lymphoma to study the characteristics of patients with leukemic phase of ALCL'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD', 'ADULT', 'OLDER_ADULT'], 'minimumAge': '9 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Patients presenting a leukemic phase of anaplastic lymphoma', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Patients presenting a leukemic phase of anaplastic lymphoma\n\nExclusion Criteria:\n\n* None'}, 'identificationModule': {'nctId': 'NCT04908059', 'acronym': 'LEUK-ALCL', 'briefTitle': 'Leukemic Phase of ALCL', 'organization': {'class': 'OTHER', 'fullName': 'University Hospital, Strasbourg, France'}, 'officialTitle': 'Leukemic Phase of ALK+ Anaplastic Lymphoma in Real-life Practice: Experience of a University Clinical Hematology Laboratory', 'orgStudyIdInfo': {'id': '8115'}}, 'contactsLocationsModule': {'locations': [{'zip': '67091', 'city': 'Strasbourg', 'status': 'RECRUITING', 'country': 'France', 'contacts': [{'name': 'Laurent MAUVIEUX, MD, PhD', 'role': 'CONTACT', 'email': 'laurent.mauvieux@chru-strasbourg.fr', 'phone': '33 3 88 12 75 27'}, {'name': 'Saïd CHAYER, PhD, HDR', 'role': 'CONTACT', 'email': 'said.chayer@chru-strasbourg.fr', 'phone': '33 3 88 11 66 90'}, {'name': 'Laurent MAUVIEUX, MD, PhD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Hematology Laboratory - Strasbourg University Hospitals', 'geoPoint': {'lat': 48.58392, 'lon': 7.74553}}], 'centralContacts': [{'name': 'Laurent MAUVIEUX, MD, PhD', 'role': 'CONTACT', 'email': 'laurent.mauvieux@chru-strasbourg.fr', 'phone': '33 3 88 12 75 27'}, {'name': 'Saïd CHAYER, PhD, HDR', 'role': 'CONTACT', 'email': 'said.chayer@chru-strasbourg.fr', 'phone': '33 3 88 11 66 90'}], 'overallOfficials': [{'name': 'Laurent MAUVIEUX, MD, PhD', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Hematology Laboratory - Strasbourg University Hospitals'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'University Hospital, Strasbourg, France', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR'}}}}